| ROSEN, THE FIRST FILING FIRM, Encourages Webull Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BULL |
Globe Newswire |
11/08 |
18:46 |
| Pope arrives in Argentina and tells Milei that people, not the economy, should come first |
AP Online |
11/08 |
18:40 |
| FireFly’s drilling results extend high-grade core zone laterally |
Globe Newswire |
11/08 |
17:46 |
| The Kremlin hopes the US election shake-up won't shift Trump's negotiations on Ukraine |
AP Online |
11/08 |
17:38 |
| ROSEN, THE FIRST FILING FIRM, Encourages UP Fintech Holding Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TIGR |
Globe Newswire |
11/08 |
17:23 |
| INVESTOR ALERT: RGRD Law Announces that D-Wave Quantum Inc. (QBTS) Investors with Substantial Losses May Seek to Lead Class Action Lawsuit |
Globe Newswire |
11/08 |
16:59 |
| Mineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026 |
Globe Newswire |
11/08 |
16:35 |
| RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges |
Globe Newswire |
11/08 |
16:01 |
| CIDEB siRNA Normalizes Liver Fat and Improves Liver Injury Markers in MASLD Patients, as Highlighted at AASLD |
Globe Newswire |
11/08 |
16:00 |
| AVITA Medical to Host Investor Webinar Briefing |
Globe Newswire |
11/08 |
15:30 |
| 3 games, 2 days, 1 program. The Bethesda men's basketball team does things very differently |
AP Online |
11/08 |
14:35 |
| Saudi Arabia turns to Syria for help as fighting with Houthis escalates |
AP Online |
11/08 |
13:57 |
| South Africa's ANC is humbled by its worst election results as it continues its decline |
AP Online |
11/08 |
13:57 |
| Bronstein, Gewirtz & Grossman LLC Urges Duolingo, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
11/08 |
13:00 |
| Bronstein, Gewirtz & Grossman LLC Urges FuelCell Energy, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
11/08 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges AST SpaceMobile, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
11/08 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges Ryde Group Ltd Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
11/08 |
12:00 |
| SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Endava plc (NYSE: DAVA) — Investors Who Suffered Losses Are Encouraged to Contact the Firm |
Globe Newswire |
11/08 |
12:00 |
| SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Coastal Financial Corporation (NASDAQ: CCB) — Investors Who Suffered Losses Are Encouraged to Contact the Firm |
Globe Newswire |
11/08 |
12:00 |
| SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Honeywell Aerospace, Inc. (NASDAQ: HONA) — Investors Who Suffered Losses Are Encouraged to Contact the Firm |
Globe Newswire |
11/08 |
12:00 |
| Gildan Activewear Inc. (GIL) Investor Alert: GIL Stock Drops Further Amid Poor Q3 Earnings; December 14, 2026 Deadline - Contact Kessler Topaz Meltzer & Check, LLP |
Globe Newswire |
11/08 |
10:33 |
| Velinotamig, a BCMAxCD3 T Cell Engager, Achieves Complete Renal Responses and Significantly Reduces Disease Activity in Systemic Lupus Erythematosus in Data Presented at ACR Convergence 2026 |
Globe Newswire |
11/08 |
10:30 |
| Colin Kaepernick honored as Humanitarian of the Year at 2026 Muhammad Ali Humanitarian Awards |
Globe Newswire |
11/08 |
10:00 |
| SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against D-Wave Quantum Inc. (NASDAQ: QBTS) — Investors Who Suffered Losses Are Encouraged to Contact the Firm |
Globe Newswire |
11/08 |
10:00 |
| Cabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable Benefit-Risk Profile Across Autoimmune Diseases |
Globe Newswire |
11/08 |
10:00 |
